Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Trifecta Capital Advisors LLC

Trifecta Capital Advisors LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,514 shares of the medical equipment provider’s stock after acquiring an additional 655 shares during the period. Intuitive Surgical accounts for about 1.2% of Trifecta Capital Advisors LLC’s holdings, making the stock its 27th biggest position. Trifecta Capital Advisors LLC’s holdings in Intuitive Surgical were worth $6,010,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $558,807,000. FMR LLC increased its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the period. Strategic Financial Concepts LLC boosted its stake in shares of Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after acquiring an additional 312,056 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Stifel Nicolaus boosted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 0.1 %

Shares of Intuitive Surgical stock opened at $591.01 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market cap of $210.51 billion, a PE ratio of 92.20, a P/E/G ratio of 5.85 and a beta of 1.39. The business’s fifty day moving average is $566.43 and its two-hundred day moving average is $526.49.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,720,023. The trade was a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,240 shares of company stock valued at $3,529,040 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.